Balkema Gary S. 4
4 · PLx Pharma Inc. · Filed Nov 20, 2020
Insider Transaction Report
Form 4
PLx Pharma Inc.PLXP
Balkema Gary S.
Director
Transactions
- Award
Stock Option (right to buy)
2020-11-18+40,000→ 40,000 totalExercise: $5.15Exp: 2030-11-18→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan.
- [F2]These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.